WallStreetZenWallStreetZen

NASDAQ: ACST
Acasti Pharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ACST past revenue growth

How has ACST's revenue growth performed historically?
Company
N/A
Industry
100.74%
Market
13.73%
ACST's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ACST's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ACST earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$41.9M
Current Profit Margin
0%

ACST Return on Equity

Current Company
-51%
Current Industry
1.4%
Current Market
22.1%
ACST's Return on Equity (-51%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ACST announces earnings.

ACST Return on Assets

Current Company
-43%
Current Industry
-1.3%
ACST is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ACST Return on Capital Employed

Current Company
-72.49%
Current Industry
12.1%
ACST has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ACST vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ACST$0.00-$51.55M-$41.93M-100.00%N/A
DOMH$71.00k-$25.89M-$25.92M-34.70%N/A
IMPL$19.05M-$77.58M-$91.56M+264.17%N/A
ATHE$0.00-$8.90M-$8.97MN/AN/A
GOVX$0.00-$19.25M-$19.32M-100.00%N/A
View Top Biotech Stocks

ACST earnings dates

Next earnings date
Nov 13, 2023

Acasti Pharma Earnings & Revenue FAQ

What were ACST's earnings last quarter?

On Invalid Date, Acasti Pharma (NASDAQ: ACST) reported Q2 2023 earnings per share (EPS) of -$0.54, up 11.48% year over year. Total Acasti Pharma earnings for the quarter were -$4.02 million. In the same quarter last year, Acasti Pharma's earnings per share (EPS) was -$0.61.

If you're new to stock investing, here's how to buy Acasti Pharma stock.

What was ACST's earnings growth in the past year?

As of Q3 2023, Acasti Pharma's earnings has grown year over year. Acasti Pharma's earnings in the past year totalled -$41.93 million.

What is ACST's earnings date?

Acasti Pharma's earnings date is Invalid Date. Add ACST to your watchlist to be reminded of ACST's next earnings announcement.

What was ACST's revenue last quarter?

On Invalid Date, Acasti Pharma (NASDAQ: ACST) reported Q2 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Acasti Pharma's revenue was $0.00.

What was ACST's revenue growth in the past year?

As of Q3 2023, Acasti Pharma's revenue has grown null year over year. Acasti Pharma's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.